As of December 2024, Celltrion Pharm has a market cap of $1.76B. This makes Celltrion Pharm the world's 5506th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.94B | 11.50% |
2023 | $2.64B | 44.71% |
2022 | $1.82B | -43.53% |
2021 | $3.23B | -46.30% |
2020 | $6.02B | 511.49% |
2019 | $983.86M | -34.19% |
2018 | $1.49B | 3.76% |
2017 | $1.44B | 161.19% |
2016 | $551.64M | 42.59% |
2015 | $386.89M | 98.12% |
2014 | $195.28M | -7.62% |
2013 | $211.39M | -49.70% |
2012 | $420.24M | - |